Oncology Pharma Inc. (ONPH)
- Previous Close
0.0000 - Open
0.0001 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0001 - 52 Week Range
0.0000 - 1.0500 - Volume
1,286 - Avg. Volume
1,894 - Market Cap (intraday)
379 - Beta (5Y Monthly) 10.78
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.
www.oncology-pharma.comRelated News
Performance Overview: ONPH
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ONPH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ONPH
Valuation Measures
Market Cap
18.98k
Enterprise Value
18.98k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
0.20
Enterprise Value/EBITDA
-0.03
Financial Highlights
Profitability and Income Statement
Profit Margin
1,821.37%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
10.21k
Net Income Avi to Common (ttm)
-15.27k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
3.21k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Company Insights: ONPH
ONPH does not have Company Insights